CS
DVAX

Credit Suisse’s Dynavax Technologies DVAX Stock Holding History

Credit Suisse’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-250,000
Closed -$1.83M – 4129
2019
Q1 		$1.83M Buy
250,000
+167,500
+203% +$1.64M ﹤0.01% 2442
2018
Q4 		$755K Buy
+82,500
New +$913K ﹤0.01% 3006

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Credit Suisse's DVAX Position: Q1 2024 in Review

Credit Suisse reduced its Dynavax Technologies (DVAX) stake by 0.11% in Q1 2024, selling an estimated $2.79K and leaving 199,920 shares worth $2.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1718.

Credit Suisse first reported a position in DVAX in Q2 2013 and has held it in 44 quarters since. The position peaked at $4.61M in Q3 2017. 244 funds tracked by Wall St. Rank hold DVAX as of Q1 2024.

  • Credit Suisse held 199,920 shares of Dynavax Technologies worth $2.48M as of Q1 2024.
  • Credit Suisse sold 214 Dynavax Technologies shares in Q1 2024, an estimated $2.79K.
  • Dynavax Technologies made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1718 holding.
  • Credit Suisse first reported a position in Dynavax Technologies in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Dynavax Technologies position peaked at $4.61M in Q3 2017.
  • 244 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.